• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MUC1 预后标志物与膀胱癌代谢和耐药性相关:一项生物信息学研究。

A prognosis marker MUC1 correlates with metabolism and drug resistance in bladder cancer: a bioinformatics research.

机构信息

Gansu Nephro-Urological Clinical Center, Institute of Urology, Department of Urology, Key Laboratory of Urological Disease of Gansu Province, Lanzhou University Second Hospital, Lanzhou, China.

Department of Urology, Lanzhou University Second Hospital, No. 82, Cuiyingmen, Chengguan District, Lanzhou, 730030, Gansu, China.

出版信息

BMC Urol. 2022 Jul 25;22(1):114. doi: 10.1186/s12894-022-01067-8.

DOI:10.1186/s12894-022-01067-8
PMID:35879749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9309451/
Abstract

BACKGROUND

MUC1 is a type I transmembrane protein that plays an important role in tumor cell signal transduction. Although current studies have shown that MUC1 is upregulated in bladder cancer (BC), the specific mechanism is still unclear.

METHODS

We performed expression analysis, gene set enrichment analysis, survival analysis, immune infiltration analysis, drug sensitivity analysis, and metabolism-related gene expression analysis on TCGA-BLCA, GES31684 and GSE13507.

RESULTS

The expression of MUC1 in the tumor and lymphatic metastasis positive samples was significantly increased. Genes related to MUC1 expression were significantly enriched in immune response, ribosomes, exosomes, and energy metabolism. The results of the immune infiltration analysis showed that M1 macrophages in BC with high MUC1 expression were significantly decreased. Expression of MUC1 increases drug resistance in BC patients. In addition, MUC1 increases glycolysis, glucose uptake, and lactate production by inducing metabolic reprogramming.

CONCLUSION

MUC1 has a significant effect on the metabolism and immune cell infiltration of BC, which may be the cause of increased drug resistance, and can be used as a molecular target for the diagnosis and treatment of BC.

摘要

背景

MUC1 是一种 I 型跨膜蛋白,在肿瘤细胞信号转导中发挥重要作用。尽管目前的研究表明 MUC1 在膀胱癌(BC)中上调,但具体机制尚不清楚。

方法

我们对 TCGA-BLCA、GES31684 和 GSE13507 进行了表达分析、基因集富集分析、生存分析、免疫浸润分析、药物敏感性分析和代谢相关基因表达分析。

结果

MUC1 在肿瘤和淋巴转移阳性样本中的表达显著增加。与 MUC1 表达相关的基因在免疫反应、核糖体、外泌体和能量代谢中显著富集。免疫浸润分析结果表明,高 MUC1 表达的 BC 中 M1 巨噬细胞显著减少。MUC1 的表达增加了 BC 患者的药物耐药性。此外,MUC1 通过诱导代谢重编程增加糖酵解、葡萄糖摄取和乳酸生成。

结论

MUC1 对 BC 的代谢和免疫细胞浸润有显著影响,这可能是增加药物耐药性的原因,可作为 BC 诊断和治疗的分子靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/7098e5d71c52/12894_2022_1067_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/a65cee74ab34/12894_2022_1067_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/9c24304e02ca/12894_2022_1067_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/099f6e6382d0/12894_2022_1067_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/7c0abed5dde7/12894_2022_1067_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/7098e5d71c52/12894_2022_1067_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/a65cee74ab34/12894_2022_1067_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/9c24304e02ca/12894_2022_1067_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/099f6e6382d0/12894_2022_1067_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/7c0abed5dde7/12894_2022_1067_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbe6/9310458/7098e5d71c52/12894_2022_1067_Fig5_HTML.jpg

相似文献

1
A prognosis marker MUC1 correlates with metabolism and drug resistance in bladder cancer: a bioinformatics research.MUC1 预后标志物与膀胱癌代谢和耐药性相关:一项生物信息学研究。
BMC Urol. 2022 Jul 25;22(1):114. doi: 10.1186/s12894-022-01067-8.
2
Co-expression of HER3 and MUC1 is associated with a favourable prognosis in patients with bladder cancer.HER3 和 MUC1 的共表达与膀胱癌患者的良好预后相关。
BJU Int. 2015 Jan;115(1):163-5. doi: 10.1111/bju.12658.
3
Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.基于未折叠蛋白反应相关基因的新型标志物鉴定用于预测膀胱癌的预后。
Hum Genomics. 2021 Dec 20;15(1):73. doi: 10.1186/s40246-021-00372-x.
4
Role of the MUC1-C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma.MUC1-C 癌蛋白在尿路上皮癌获得顺铂耐药中的作用。
Cancer Sci. 2020 Oct;111(10):3639-3652. doi: 10.1111/cas.14574. Epub 2020 Aug 11.
5
Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis.跨膜黏蛋白MUC1和MUC4在膀胱癌中的表达改变:对诊断的病理意义
PLoS One. 2014 Mar 26;9(3):e92742. doi: 10.1371/journal.pone.0092742. eCollection 2014.
6
MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer.MUC1 介导的代谢改变调节胰腺癌对放疗的反应。
Clin Cancer Res. 2017 Oct 1;23(19):5881-5891. doi: 10.1158/1078-0432.CCR-17-1151. Epub 2017 Jul 18.
7
AGR2-induced glucose metabolism facilitated the progression of endometrial carcinoma via enhancing the MUC1/HIF-1α pathway.AGR2 诱导的葡萄糖代谢通过增强 MUC1/HIF-1α 通路促进子宫内膜癌的进展。
Hum Cell. 2020 Jul;33(3):790-800. doi: 10.1007/s13577-020-00356-4. Epub 2020 Apr 18.
8
Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.开发和验证一种新型的与脂质代谢相关的基因预后标志物,并为膀胱癌患者找到候选药物。
Lipids Health Dis. 2021 Oct 27;20(1):146. doi: 10.1186/s12944-021-01554-1.
9
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.MUC1-C 可将 IFN-γ 通路的激活与三阴性乳腺癌肿瘤免疫微环境的抑制相结合。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-002115.
10
The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.基于 TCGA 的膀胱癌 PTPN6 分析:一项探索性研究。
Dis Markers. 2020 May 13;2020:4312629. doi: 10.1155/2020/4312629. eCollection 2020.

引用本文的文献

1
The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review.黏蛋白在癌症及癌症进展中的作用:综述
Curr Issues Mol Biol. 2025 May 29;47(6):406. doi: 10.3390/cimb47060406.
2
A mini-review-cancer energy reprogramming on drug resistance and immune response.一篇关于癌症能量重编程对耐药性和免疫反应的小型综述
Transl Oncol. 2024 Nov;49:102099. doi: 10.1016/j.tranon.2024.102099. Epub 2024 Aug 19.
3
CD44 in Bladder Cancer.膀胱癌中的CD44

本文引用的文献

1
A novel humanized MUC1 antibody-drug conjugate for the treatment of trastuzumab-resistant breast cancer.一种新型人源化 MUC1 抗体药物偶联物,用于治疗曲妥珠单抗耐药的乳腺癌。
Acta Biochim Biophys Sin (Shanghai). 2021 Dec 8;53(12):1625-1639. doi: 10.1093/abbs/gmab141.
2
Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.乳腺癌免疫浸润模式下的免疫微环境景观。
Front Immunol. 2021 Aug 27;12:711433. doi: 10.3389/fimmu.2021.711433. eCollection 2021.
3
MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.
Cancers (Basel). 2024 Mar 18;16(6):1195. doi: 10.3390/cancers16061195.
4
Current look at the most promising proteomic and glycomic biomarkers of bladder cancer.当前对膀胱癌最有前途的蛋白质组学和糖组学生物标志物的研究。
J Cancer Res Clin Oncol. 2024 Feb 19;150(2):96. doi: 10.1007/s00432-024-05623-7.
5
Altered Glycosylation in Progression and Management of Bladder Cancer.膀胱癌进展和管理中的糖基化改变。
Molecules. 2023 Apr 13;28(8):3436. doi: 10.3390/molecules28083436.
6
The multifaceted role of MUC1 in tumor therapy resistance.MUC1 在肿瘤治疗耐药中的多效性作用。
Clin Exp Med. 2023 Sep;23(5):1441-1474. doi: 10.1007/s10238-022-00978-y. Epub 2022 Dec 23.
7
Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer.膀胱癌中关键RNA结合蛋白的综合分析与鉴定
Cancers (Basel). 2022 Jul 31;14(15):3739. doi: 10.3390/cancers14153739.
MUC1:在上皮性癌症中的结构、功能与临床应用。
Int J Mol Sci. 2021 Jun 18;22(12):6567. doi: 10.3390/ijms22126567.
4
MUC1 regulates AKT signaling pathway by upregulating EGFR expression in ovarian cancer cells.MUC1通过上调卵巢癌细胞中EGFR的表达来调节AKT信号通路。
Pathol Res Pract. 2021 Aug;224:153509. doi: 10.1016/j.prp.2021.153509. Epub 2021 Jun 4.
5
Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.MUC1 的抑制促进了胰腺和乳腺癌小鼠模型中髓源性抑制细胞的扩增和抑制功能。
Int J Mol Sci. 2021 May 25;22(11):5587. doi: 10.3390/ijms22115587.
6
GLUT1 biological function and inhibition: research advances.GLUT1 的生物学功能及其抑制:研究进展。
Future Med Chem. 2021 Jul;13(14):1227-1243. doi: 10.4155/fmc-2021-0071. Epub 2021 May 21.
7
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling.MUC1与VEGF在血管生成和转移中的相互作用:一篇综述,重点介绍MUC1的作用,着重于转移和血管生成信号传导。
Cancer Cell Int. 2021 Apr 9;21(1):200. doi: 10.1186/s12935-021-01899-8.
8
Hypoxia and its Modification in Bladder Cancer: Current and Future Perspectives.膀胱癌中的缺氧及其修饰:现状与未来展望。
Clin Oncol (R Coll Radiol). 2021 Jun;33(6):376-390. doi: 10.1016/j.clon.2021.03.001. Epub 2021 Mar 21.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.MRPL13是一种预后性癌症生物标志物,与乳腺癌中的免疫浸润相关。
Onco Targets Ther. 2020 Nov 27;13:12255-12268. doi: 10.2147/OTT.S263998. eCollection 2020.